Krka Investigated for Suspected Anti-Trust Deal
Brussels, 8 July - The European Commission announced on Wednesday that it had launched formal proceedings against Slovenian drug maker Krka and four other generic pharma companies as part of an anti-trust probe at French Les Laboratoires Servier.
Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA
Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA
Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA
Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA
The rest of this news item is available to subscribers.
The news item consists of 2.598 characters (without spaces) or 497 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.